{"id":"W1859257957","doi":"10.1002/path.4287","title":"Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours","year":2013,"lang":"en","type":"review","venue":"The Journal of Pathology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1347,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Labex Immuno-Oncology; Cancer Research Institute; Qatar National Research Fund; Institut National de la Santé et de la Recherche Médicale; Institut National Du Cancer; Assistance publique-Hôpitaux de Paris; Fonds National de la Recherche Luxembourg; European Commission; Pathological Society of Great Britain and Ireland; National Center for Advancing Translational Sciences; Japan Association for Chemical Innovation; Society for Immunotherapy of Cancer","keywords":"Medicine; Oncology; Colorectal cancer; Cancer staging; Cancer; Stage (stratigraphy); Internal medicine; Immune system; TNM staging system; Neoplasm staging; Immunology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07554092438918289,"score_gpt":0.3444991782666527,"score_spread":0.2689582538774699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}